These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 8638406)

  • 21. Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
    Malet I; Roquebert B; Dalban C; Wirden M; Amellal B; Agher R; Simon A; Katlama C; Costagliola D; Calvez V; Marcelin AG
    J Infect; 2007 Apr; 54(4):367-74. PubMed ID: 16875739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.
    Lastere S; Dalban C; Collin G; Descamps D; Girard PM; Clavel F; Costagliola D; Brun-Vezinet F;
    Antivir Ther; 2004 Apr; 9(2):221-7. PubMed ID: 15134184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
    Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
    Larrouy L; Vivot A; Charpentier C; Bénard A; Visseaux B; Damond F; Matheron S; Chene G; Brun-Vezinet F; Descamps D;
    AIDS; 2013 Jan; 27(1):69-80. PubMed ID: 23018441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden.
    Leitner T; Escanilla D; Marquina S; Wahlberg J; Broström C; Hansson HB; Uhlén M; Albert J
    Virology; 1995 May; 209(1):136-46. PubMed ID: 7747463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
    Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
    Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitination of HIV-1 and MuLV Gag.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U
    Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of HIV-1 CRF07_BC gag p6 sequences indicating novel deletions in the central region of p6.
    Song YH; Meng ZF; Xing H; Ruan YH; Li XP; Xin RL; Ma PF; Peng H; Shao Y
    Arch Virol; 2007; 152(8):1553-8. PubMed ID: 17458619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes.
    Renjifo B; Fawzi W; Mwakagile D; Hunter D; Msamanga G; Spiegelman D; Garland M; Kagoma C; Kim A; Chaplin B; Hertzmark E; Essex M
    J Hum Virol; 2001; 4(1):16-25. PubMed ID: 11213929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in p1-p6/p6* of HIV type 1 can delay protease autoprocessing and increase drug susceptibility.
    Whitehurst N; Chappey C; Petropoulos C; Parkin N; Gamarnik A
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):779-84. PubMed ID: 14585208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?
    de Oliveira T; Engelbrecht S; Janse van Rensburg E; Gordon M; Bishop K; zur Megede J; Barnett SW; Cassol S
    J Virol; 2003 Sep; 77(17):9422-30. PubMed ID: 12915557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro.
    Maguire MF; Guinea R; Griffin P; Macmanus S; Elston RC; Wolfram J; Richards N; Hanlon MH; Porter DJ; Wrin T; Parkin N; Tisdale M; Furfine E; Petropoulos C; Snowden BW; Kleim JP
    J Virol; 2002 Aug; 76(15):7398-406. PubMed ID: 12097552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Within-host co-evolution of Gag P453L and protease D30N/N88D demonstrates virological advantage in a highly protease inhibitor-exposed HIV-1 case.
    Shibata J; Sugiura W; Ode H; Iwatani Y; Sato H; Tsang H; Matsuda M; Hasegawa N; Ren F; Tanaka H
    Antiviral Res; 2011 Apr; 90(1):33-41. PubMed ID: 21338625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
    Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates.
    Knops E; Däumer M; Awerkiew S; Kartashev V; Schülter E; Kutsev S; Brakier-Gingras L; Kaiser R; Pfister H; Verheyen J
    J Antimicrob Chemother; 2010 Jul; 65(7):1472-6. PubMed ID: 20430786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.